Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.95 USD
Change Today +0.02 / 0.25%
Volume 1.4K
ICCC On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

immucell corp (ICCC) Snapshot

Open
$7.93
Previous Close
$7.93
Day High
$7.97
Day Low
$7.93
52 Week High
05/20/15 - $8.69
52 Week Low
10/10/14 - $3.96
Market Cap
24.1M
Average Volume 10 Days
3.9K
EPS TTM
$0.09
Shares Outstanding
3.0M
EX-Date
--
P/E TM
88.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMUCELL CORP (ICCC)

Related News

No related news articles were found.

immucell corp (ICCC) Related Businessweek News

No Related Businessweek News Found

immucell corp (ICCC) Details

ImmuCell Corporation develops, acquires, manufactures, and sells products that enhance animal health and productivity in the dairy and beef industries in the United States and internationally. The company offers First Defense, an orally delivered scours preventive product, which provides bovine antibodies for newborn calves; Wipe Out Dairy Wipes, which consist of towelettes that are pre-moistened with a Nisin-based formulation to prepare the teat area of a cow in advance of milking; and California Mastitis Test that is used for bulk tank and individual cow sample monitoring, as well as to determine which quarter of the udder is mastitic. It is also involved in the development of Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows; and treatments that prevent calf scours caused by enteric pathogens in addition to E. coli K99 and bovine coronavirus. In addition, the company sells various product applications of its First Defense Technology, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products to distributors and bovine veterinarians, as well as directly to producers. The company was founded in 1982 and is based in Portland, Maine.

34 Employees
Last Reported Date: 05/12/15
Founded in 1982

immucell corp (ICCC) Top Compensated Officers

Chief Executive Officer, President, Chief Fin...
Total Annual Compensation: $266.9K
Chief Scientific Officer, Vice President and ...
Total Annual Compensation: $77.4K
Vice President of Sales and Marketing
Total Annual Compensation: $180.2K
Compensation as of Fiscal Year 2014.

immucell corp (ICCC) Key Developments

ImmuCell Corporation Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Full Year of 2015

ImmuCell Corporation reported unaudited earnings results for the first quarter ended March 31, 2015. Total sales increased 49% to $3.10 million compared to $2.1 million for the first quarter of 2014. Net operating income was $0.8 million compared to $0.013 million for the first quarter of 2014. Income before income taxes was $0.815 million compared to $0.001 million for the first quarter of 2014. Net income was $0.5 million or $0.15 per diluted share against net loss of $0.013 million or $0.00 per basic and diluted share last year. The company expects positive year-to-date sales growth throughout 2015, in comparison to the same periods in 2014. Gross margin can consistently be above 50% on an annual basis.

ImmuCell Corp. to Report Q1, 2015 Results on May 12, 2015

ImmuCell Corp. announced that they will report Q1, 2015 results After-Market on May 12, 2015

ImmuCell Corp., Q1 2015 Earnings Call, May 12, 2015

ImmuCell Corp., Q1 2015 Earnings Call, May 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICCC:US $7.95 USD +0.02

ICCC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Novartis AG SFr.93.30 CHF +0.35
Zoetis Inc $48.40 USD +0.09
View Industry Companies
 

Industry Analysis

ICCC

Industry Average

Valuation ICCC Industry Range
Price/Earnings 74.5x
Price/Sales 2.8x
Price/Book 2.5x
Price/Cash Flow 73.8x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUCELL CORP, please visit www.immucell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.